Cytokinetics
CYTK
#2249
Rank
โ‚น760.25 B
Marketcap
โ‚น6,173
Share price
4.67%
Change (1 day)
79.41%
Change (1 year)

Market capitalization of Cytokinetics (CYTK)

Market cap: โ‚น760.25 Billion

As of April 2026 Cytokinetics has a market cap of โ‚น760.25 Billion. This makes Cytokinetics the world's 2249th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Cytokinetics from 2004 to 2026

End of year Market Cap

Year Marketcap Change
2026โ‚น760.25 B9.76%
2025โ‚น692.67 B44.47%
2024โ‚น479.47 B-29.65%
2023โ‚น681.51 B89.94%
2022โ‚น358.80 B25.32%
2021โ‚น286.31 B166.18%
2020โ‚น107.56 B140.26%
2019โ‚น44.77 B85.15%
2018โ‚น24.18 B-13.77%
2017โ‚น28.04 B-16.38%
2016โ‚น33.53 B21.88%
2015โ‚น27.51 B40.19%
2014โ‚น19.62 B59.29%
2013โ‚น12.32 B139.33%
2012โ‚น5.14 B40.25%
2011โ‚น3.67 B-41.42%
2010โ‚น6.26 B-24.26%
2009โ‚น8.27 B20.94%
2008โ‚น6.84 B-25.22%
2007โ‚น9.14 B-36.2%
2006โ‚น14.33 B81.5%
2005โ‚น7.90 B-33.7%
2004โ‚น11.91 B

End of Day market cap according to different sources

On Mar 31st, 2026 the market cap of Cytokinetics was reported to be:

โ‚น760.25 Billion
by Nasdaq info icon info icon
โ‚น760.25 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Amgen
AMGN
โ‚น17.763 T 2,236.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Trevena
TRVN
โ‚น0.88 M-100.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
โ‚น372.85 B-50.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
โ‚น76.89 M-99.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Array Technologies
ARRY
โ‚น103.49 B-86.39%๐Ÿ‡บ๐Ÿ‡ธ USA